Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
Sales | 200,563 | 181,778 | 180,010 | 174,436 | 154,022 |
Cost of Goods | 34,023 | 29,846 | 30,850 | 30,098 | 24,994 |
Gross Profit | 166,540 | 151,932 | 149,160 | 144,338 | 129,028 |
Operating Expenses | 104,208 | 102,458 | 103,262 | 96,869 | 85,256 |
Operating Income | 62,355 | 50,320 | 46,748 | 47,567 | 44,766 |
Other Income | 2,155 | 1,513 | 1,739 | 940 | 888 |
Pre-tax Income | 64,510 | 51,833 | 48,487 | 48,507 | 45,654 |
Income Tax | 19,648 | 1,706 | -41,579 | 11,660 | 32,208 |
Net Income Continuous | 44,862 | 50,127 | 90,066 | 36,847 | 13,446 |
Net Income | $44,862 | $50,127 | $90,066 | $36,847 | $13,446 |
EPS Basic Total Ops | 1.00 | 1.11 | 2.02 | 0.83 | 0.30 |
EPS Basic Continuous Ops | 1.00 | 1.11 | 2.02 | 0.83 | 0.30 |
EPS Diluted Total Ops | 0.97 | 1.09 | 1.95 | 0.80 | 0.29 |
EPS Diluted Continuous Ops | 0.97 | 1.09 | 1.95 | 0.80 | 0.29 |
EBITDA(a) | $65,944 | $53,708 | $49,707 | $50,472 | $47,546 |